Showing 1 - 1 results of 1 for search 'Ricardo Papaléo Rosim', query time: 0.02s Refine Results
  1. 1
    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.

    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach. by Guilherme Silva Julian, Ricardo Papaléo Rosim, Estela Cristina Carneseca, Jéssica Rigolon

    Published 2020-01-01
    Get full text
    Article

Search Tools: